Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.

Kourkoumpetis TK, Velmahos GC, Ziakas PD, Tampakakis E, Manolakaki D, Coleman JJ, Mylonakis E.

Mycopathologia. 2011 Feb;171(2):85-91. doi: 10.1007/s11046-010-9369-3. Epub 2010 Oct 8.

3.

Risk factors for fluconazole-resistant candidemia.

Garnacho-Montero J, Díaz-Martín A, García-Cabrera E, Ruiz Pérez de Pipaón M, Hernández-Caballero C, Aznar-Martín J, Cisneros JM, Ortiz-Leyba C.

Antimicrob Agents Chemother. 2010 Aug;54(8):3149-54. doi: 10.1128/AAC.00479-10. Epub 2010 May 24.

4.

Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.

Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P.

Jpn J Infect Dis. 2005 Dec;58(6):344-8.

5.

Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.

Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.

AIDS. 1994 Jul;8(7):945-50.

PMID:
7946104
6.

Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.

Panizo MM, Reviákina V, Dolande M, Selgrad S.

Med Mycol. 2009 Mar;47(2):137-43. doi: 10.1080/13693780802144339. Epub 2008 Jun 27.

PMID:
18651308
7.
8.

Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.

Ozhak-Baysan B, Ogunc D, Colak D, Ongut G, Donmez L, Vural T, Gunseren F.

Med Mycol. 2012 Jul;50(5):529-32. doi: 10.3109/13693786.2011.618996. Epub 2011 Oct 11.

PMID:
21988703
9.

Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.

Wang JL, Chang SC, Hsueh PR, Chen YC.

J Microbiol Immunol Infect. 2004 Aug;37(4):236-41.

PMID:
15340652
10.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
11.

The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study.

Kim SH, Shin JH, Kim EC, Lee K, Kim MN, Lee WG, Uh Y, Lee HS, Lee MK, Jeong SH, Jung SI, Park KH, Lee JS, Shin MG, Suh SP, Ryang DW.

Med Mycol. 2009 May;47(3):296-304. doi: 10.1080/13693780802291445. Epub 2008 Jul 30.

PMID:
18668423
12.

Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.

Colombo AL, Nakagawa Z, Valdetaro F, Branchini ML, Kussano EJ, Nucci M.

Med Mycol. 2003 Jun;41(3):235-9.

PMID:
12964715
13.

Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010-2011.

Maldonado NA, Cano LE, De Bedout C, Arbeláez CA, Roncancio G, Tabares AM, Robledo CG, Robledo J; Grupo GERMEN.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):280-6. doi: 10.1016/j.diagmicrobio.2014.02.003. Epub 2014 Feb 22.

PMID:
24666706
14.

Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital.

Ying Y, Zhang J, Huang SB, Liu FD, Liu JH, Zhang J, Hu XF, Zhang ZQ, Liu X, Huang XT.

Indian J Med Microbiol. 2015 Jul-Sep;33(3):413-5. doi: 10.4103/0255-0857.158569. Erratum in: Indian J Med Microbiol. 2015 Oct-Dec;33(4):621.

15.

In vitro activity of voriconazole against Candida species isolated in Taiwan.

Yang YL, Cheng HH, Lo HJ.

Int J Antimicrob Agents. 2004 Sep;24(3):294-6.

PMID:
15325436
16.

Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

Oxman DA, Chow JK, Frendl G, Hadley S, Hershkovitz S, Ireland P, McDermott LA, Tsai K, Marty FM, Kontoyiannis DP, Golan Y.

J Antimicrob Chemother. 2010 Jul;65(7):1460-5. doi: 10.1093/jac/dkq136. Epub 2010 Apr 29.

PMID:
20430790
17.

[Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].

Skrodeniene E, Dambrauskiene A, Vitkauskiene A.

Medicina (Kaunas). 2006;42(4):294-9. Lithuanian.

18.

Rapid identification of fluconazole resistance using Chrom agar Candida.

Verghese SL, Padmaja P, Sutha P, Mathew T, Johni ES.

Indian J Pathol Microbiol. 2001 Jul;44(3):305-7.

19.

Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?

Kovacicova G, Krupova Y, Lovaszova M, Roidova A, Trupl J, Liskova A, Hanzen J, Milosovic P, Lamosova M, Macekova L, Szovenyiova Z, Purgelova A, Obertik T, Bille J, Krcmery V.

J Infect Chemother. 2000 Dec;6(4):216-21.

PMID:
11810569
20.

Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil.

Neves-Junior A, Cartágenes-Pinto AC, Rocha DA, de Sá LF, Junqueira Mde L, Ferreira-Pereira A.

An Acad Bras Cienc. 2015 Aug;87(2 Suppl):1349-59. doi: 10.1590/0001-3765201520140717. Epub 2015 Aug 25.

Supplemental Content

Support Center